How should a rectal lesion be managed when biopsy shows only a tubulovillous adenoma but MRI indicates extension into the internal sphincter and abutment of the external sphincter?

When Biopsy Shows Only Tubulovillous Adenoma But MRI Suggests Sphincter Involvement

This lesion requires complete excision with clear margins, and given the MRI findings of internal sphincter extension and external sphincter abutment, you should proceed with neoadjuvant chemoradiotherapy followed by total mesorectal excision (TME) surgery rather than local excision alone. The discordance between benign pathology and concerning imaging mandates treating this as locally advanced disease to prevent understaging and ensure oncologic adequacy.

The Critical Problem: Pathology-Imaging Discordance

The core issue here is that biopsy sampling can significantly underdiagnose the true extent of disease. A tubulovillous adenoma on biopsy does not exclude invasive cancer elsewhere in the lesion—biopsies capture only a small fraction of the tumor and are notoriously unreliable for ruling out malignancy 1, 2. The MRI findings of sphincter involvement suggest this is at minimum a T3 lesion (possibly T4 if the external sphincter is truly involved), which fundamentally changes management regardless of what the biopsy shows.

Why Local Excision Alone Is Inadequate

Local procedures like transanal endoscopic microsurgery (TEM) or transanal minimally invasive surgery (TAMIS) are only appropriate for:

• Haggitt 1-3 or T1 sm1(-2) lesions
• R0 resection with clear margins
• No vessel invasion or poor differentiation
• No sphincter involvement 3, 4

Your case fails multiple criteria:

• MRI shows extension into the internal sphincter (indicating at least T3 disease)
• The lesion abuts the external sphincter
• A simple local excision cannot achieve adequate margins with this degree of involvement

If you attempt local excision and the final pathology reveals deeper invasion (T2 or worse) or involved margins, the recurrence risk exceeds 10%, necessitating salvage TME surgery anyway 3, 4. Salvage surgery after failed local treatment yields significantly worse outcomes than upfront radical surgery 4.

The Recommended Treatment Algorithm

Step 1: Treat as Locally Advanced Disease

Given the MRI findings, this lesion falls into the "intermediate to bad" risk category (cT3 with threatened circumferential resection margin or cT4a) 3, 4.

Step 2: Neoadjuvant Chemoradiotherapy

Preoperative chemoradiotherapy is preferred over immediate surgery because:

• It is more effective and less toxic than postoperative treatment 3
• It may downstage the tumor and improve sphincter preservation chances
• For very low tumors with sphincter involvement, preoperative RT is indicated even for cT2 lesions because the distance to the mesorectal fascia is minimal 3

Regimen options:

• Standard approach: 50.4 Gy at 1.8 Gy/fraction with concurrent 5-FU-based chemotherapy (continuous infusion preferred over bolus), followed by surgery 6-8 weeks later 3
• Alternative (if patient cannot tolerate chemoRT): Short-course radiotherapy 25 Gy (5 Gy × 5 fractions) followed by immediate surgery within 10 days 3

Step 3: Total Mesorectal Excision Surgery

After neoadjuvant therapy, proceed with TME surgery 3, 4. The specific operation depends on tumor location:

• Low anterior resection if the tumor is in the mid-to-upper rectum
• Abdominoperineal resection or coloanal anastomosis for very low tumors
• Intersphincteric resection may be considered if downstaging allows sphincter preservation 5

The goal is R0 resection with adequate margins and intact mesorectal fascia.

Critical Pitfalls to Avoid

1. Do not rely on biopsy pathology alone when imaging suggests advanced disease. Biopsies sample only a tiny portion of the lesion and frequently miss invasive foci 1, 2.

2. Do not attempt local excision for lesions with sphincter involvement. This guarantees inadequate margins and high recurrence risk 3, 4.

3. Do not skip neoadjuvant therapy for locally advanced low rectal tumors. Preoperative chemoRT significantly reduces local recurrence rates compared to surgery alone 3.

4. If the patient insists on local excision despite counseling, presurgical chemoradiotherapy must be given first 3. However, this is still suboptimal compared to TME.

Special Consideration: Multidisciplinary Discussion

This case must be discussed in a multidisciplinary tumor board with experienced colorectal surgeons, radiation oncologists, medical oncologists, radiologists, and pathologists 6, 4, 7. The imaging-pathology discordance, sphincter involvement, and treatment implications require expert consensus.

What If the Final Pathology Shows Only Adenoma?

Even if the final surgical specimen confirms only tubulovillous adenoma without invasive cancer, you will have made the correct decision. The MRI findings of sphincter involvement necessitated this aggressive approach because:

• Adequate local excision was not technically feasible
• The risk of understaging was unacceptably high
• Sphincter-preserving surgery after neoadjuvant therapy may still be possible if significant downstaging occurs

The priority is preventing local recurrence and ensuring oncologic adequacy, which trumps the desire for organ preservation when imaging suggests advanced local disease 3, 6, 4.